Capricor Therapeutics (CAPR)'s 30-day implied volatility (IV30) was 299.8% at the close on November 2, 2026, down from 308.4% the day before, against a 52-week range of 50.6% to 400.0%. Its 20-day historical volatility was 92.5%.
Data as of November 2, 2026.